CYSTIC DILATATION OF NEPHRONS IN TRANSGENIC INV MICE
转基因 INV 小鼠肾单位囊性扩张
基本信息
- 批准号:6262576
- 负责人:
- 金额:$ 12.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-01 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:autosomal recessive trait chimeric proteins developmental genetics disease /disorder model electron microscopy embryogenesis genetically modified animals green fluorescent proteins immunofluorescence technique laboratory mouse light microscopy mammalian embryology messenger RNA polycystic kidney postpartum renal tubule
项目摘要
Polycystic kidney disease (PKD) is the most common inherited renal disease, accounting for 5-10% of end-stag renal disease with an annual cost of $240,000,000. The etiology of renal cysts is especially important for the children an adults with inherited PKD who may require dialysis or transplantation for survival. We have a newly describe transgenic mouse model of PKD, called inv/inv, which will be used to conduct studies not possible in humans. The long term goal of this project is to understand how the inheritance of a novel situs inversus gene, inv, results in PKD and loss of renal function. Our general strategy is to study the kidneys of inv/inv mice, which share phenotypic features with autosomal recessive (AR) PKD. They develop situs inversus, PKD and die prematurely from renal failure. The inv gene has been fully cloned and sequenced. Our preliminary data suggest inv is an intracellular protein with discrete localization in specific segments of the nephron. Our experiments will test the hypothesis that the inv gene codes for a developmentally important protein that maintains nephron integrity. Grant funding is a major factor in the PI's immediate goal of attaining research independence and the long-term career goal of becoming a successful and productive investigator in an academic institution. The specific aims of this present study are as follows: 1. To characterize the inv/inv mouse model of ARPKD, we will perform single and dual photon fluorescence microscopy with cell-specific antibodies and lectins. Immunogold electron microscopy with anti-inv antibodies will target the intracellular localization of the inv protein. These microscopy experiments will allow us to appropriately direct mechanistic studies of inv protein function and interactions. 2. In situ hybridization studies will be used to determine the cellular levels of inv messenger RNA during critical periods of development. This is especially important, as incremental variations in mRNA expression are known to occur during narrow developmental windows. 3. We will use green fluorescent protein-inv constructs and anti-inv antibodies t establish spatial and temporal inv expression patterns during development. We believe the inv/inv model offers a new an exciting opportunity to extend the understanding of the genetic mechanisms of nephrogenesis and the abnormalities in this process which lead to PKD.
多囊性肾脏疾病(PKD)是最常见的肾脏疾病,占末端纳尔肾病的5-10%,年费用为240,000,000美元。肾囊肿的病因对于可能需要透析或移植才能生存的儿童尤其重要。我们有一个新的PKD的转基因小鼠模型,称为Inv/Inv,该模型将用于进行人类进行研究。该项目的长期目标是了解新型Situs Inversus基因的遗传如何导致PKD和肾功能的丧失。我们的一般策略是研究Inv/Inv小鼠的肾脏,这些肾脏与常染色体隐性(AR)PKD共享表型特征。他们会因肾衰竭而过早地发展现场倒置,PKD并过早地死亡。 INV基因已被完全克隆和测序。我们的初步数据表明INV是一种细胞内蛋白,在肾单位的特定段中具有离散定位。我们的实验将检验以下假设:INV基因代码为维持肾单位完整性的发育重要蛋白质代码。赠款资金是PI取得研究独立性的近期目标的主要因素,也是成为学术机构中成功和生产性研究人员的长期职业目标。本研究的具体目的如下:1。为了表征ARPKD的Inv/Inv小鼠模型,我们将用细胞特异性抗体和凝集素执行单个和双光子荧光显微镜。具有抗INV抗体的免疫元电子显微镜将针对Inv蛋白的细胞内定位。这些显微镜实验将使我们能够适当地直接对INV蛋白功能和相互作用的机械研究。 2。原位杂交研究将用于确定在关键发展期间INV Messenger RNA的细胞水平。这尤其重要,因为已知在狭窄的发育窗口中已知MRNA表达的增量变化。 3。我们将使用绿色荧光蛋白INV构建体和抗INV抗体t在发育过程中建立空间和时间INV表达模式。我们认为,INV/INV模型为一个新的激动人心的机会扩展了对肾脏发生的遗传机制和此过程中导致PKD的异常的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARRIE L PHILLIPS其他文献
CARRIE L PHILLIPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARRIE L PHILLIPS', 18)}}的其他基金
Cystic Dilatation of Nephrons in Transgenic inv Mice
转基因小鼠肾单位囊性扩张
- 批准号:
6951925 - 财政年份:2004
- 资助金额:
$ 12.07万 - 项目类别:
Cystic Dilatation of Nephrons in Transgenic inv Mice
转基因小鼠肾单位囊性扩张
- 批准号:
6869238 - 财政年份:2004
- 资助金额:
$ 12.07万 - 项目类别:
CYSTIC DILATATION OF NEPHRONS IN TRANSGENIC INV MICE
转基因 INV 小鼠肾单位囊性扩张
- 批准号:
6899278 - 财政年份:2001
- 资助金额:
$ 12.07万 - 项目类别:
CYSTIC DILATATION OF NEPHRONS IN TRANSGENIC INV MICE
转基因 INV 小鼠肾单位囊性扩张
- 批准号:
6643393 - 财政年份:2001
- 资助金额:
$ 12.07万 - 项目类别:
CYSTIC DILATATION OF NEPHRONS IN TRANSGENIC INV MICE
转基因 INV 小鼠肾单位囊性扩张
- 批准号:
6516755 - 财政年份:2001
- 资助金额:
$ 12.07万 - 项目类别:
CYSTIC DILATATION OF NEPHRONS IN TRANSGENIC INV MICE
转基因 INV 小鼠肾单位囊性扩张
- 批准号:
6768651 - 财政年份:2001
- 资助金额:
$ 12.07万 - 项目类别:
相似国自然基金
基于非洲猪瘟病毒pS273R蛋白泛素-蛋白酶体降解途径阻抑机制理性设计其特异性蛋白水解靶向嵌合体的研究
- 批准号:32373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
劫持金葡菌ClpP复合物的蛋白降解靶向嵌合体设计和抗菌作用研究
- 批准号:82304572
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
可溶性嵌合蛋白FasL诱导移植免疫耐受的效果和机制研究
- 批准号:82370667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于穿膜聚多肽的肿瘤特异性蛋白降解靶向嵌合体递送及其用于KRAS突变肿瘤治疗的研究
- 批准号:52303200
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于磷酸酶PP5构建非底物蛋白去磷酸化嵌合体(PhosTAC)及其生物功能研究
- 批准号:82304309
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Engineering tools for rapid loss of protein function in model organisms
模型生物中蛋白质功能快速丧失的工程工具
- 批准号:
9356570 - 财政年份:2016
- 资助金额:
$ 12.07万 - 项目类别:
Engineering tools for rapid loss of protein function in model organisms
模型生物中蛋白质功能快速丧失的工程工具
- 批准号:
9163926 - 财政年份:2016
- 资助金额:
$ 12.07万 - 项目类别:
Systems Analysis of Conditional C. elegans Mutants with Late Embryonic Defects
具有晚期胚胎缺陷的条件性秀丽隐杆线虫突变体的系统分析
- 批准号:
9230401 - 财政年份:2015
- 资助金额:
$ 12.07万 - 项目类别:
A high throughput platform for nuclear receptor ligand and drug discovery
用于核受体配体和药物发现的高通量平台
- 批准号:
8725654 - 财政年份:2013
- 资助金额:
$ 12.07万 - 项目类别:
A high throughput platform for nuclear receptor ligand and drug discovery
用于核受体配体和药物发现的高通量平台
- 批准号:
8841343 - 财政年份:2013
- 资助金额:
$ 12.07万 - 项目类别: